Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis
Open Access
- 8 October 2003
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 23 (27) , 9162-9170
Abstract
Human immunodeficiency virus-1 (HIV-1) infection of the nervous system can result in neuroinflammatory events leading first to neuronal dysfunction then to cognitive and behavioral impairments in infected people. The multifaceted nature of the disease process, commonly called HIV-1-associated dementia (HAD), provides a number of adjunctive therapeutic opportunities. One proposed adjunctive therapy is sodium valproate (VPA), an anticonvulsant known to promote neurite outgrowth and increase β-catenin through inhibiting glycogen synthase kinase 3β activity and tau phosphorylation. We now show that VPA treatment of rat cortical neurons exposed to HIV-1 gp120 prevents resultant neurotoxic activities. This includes the induction of significant neurite outgrowth and microtubule-associated protein 2 (MAP-2) and neuron-specific nuclear protein (NeuN) antigens in affected neuronal cell bodies and processes. Similarly, VPA protects severe combined immunodeficient (SCID) mice against the neurodegeneration of HIV-1ADAinfected monocyte-derived macrophages (MDMs). In SCID mice with HIV-1 MDM-induced encephalitis, VPA treatment significantly reduced neuronal phosphorylatedβ-catenin and tau without affecting HIV-1 replication or glial activation. We conclude that VPA protects neurons against HIV-1 infected MDM neurotoxicity, possibly through its effects on the phosphorylation of tau and β-catenin. The use of VPA as an adjuvant in treatment of human HAD is being pursued.Keywords
This publication has 49 references indexed in Scilit:
- Detection of HIV‐1 DNA in Microglia/ Macrophages, Astrocytes and Neurons Isolated from Brain Tissue with HIV‐1 Encephalitis by Laser Capture MicrodissectionBrain Pathology, 2003
- Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic caspase pathwayMolecular and Cellular Neuroscience, 2003
- Mood stabilizers in Alzheimer’s disease: symptomatic and neuroprotective rationalesAdvanced Drug Delivery Reviews, 2002
- Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic miceNeuroReport, 2001
- Activation of glycogen synthase kinase 3 beta (GSK‐3β) by platelet activating factor mediates migration and cell death in cerebellar granule neuronsEuropean Journal of Neuroscience, 2001
- HIV‐1 Tat‐Mediated Activation of Glycogen Synthase Kinase‐3β Contributes to Tat‐Mediated NeurotoxicityJournal of Neurochemistry, 1999
- The Neuronal Cytoskeleton Is at Risk After Mild and Moderate Brain InjuryJournal of Neurotrauma, 1998
- A murine model of HIV encephalitis: xenotransplantation of HIV‐infected human neuroglia into SCID mouse brainNeuropathology and Applied Neurobiology, 1998
- Neocortical damage during HIV infectionAnnals of Neurology, 1991
- Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.Journal of Experimental Medicine, 1988